EU Enters Final Talks for BioNTech-Pfizer Vaccine EU Enters Final Talks for BioNTech-Pfizer Vaccine

The European Commission said on Wednesday it had entered final stage talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against COVID-19.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news